Skip to content

Clinical trials

Phase 3 Muscular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Diseases Phase: Phase 3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20141
20151
20161
20172
20212
20223
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
PTC Therapeutics3
Tonix Pharmaceuticals, Inc.2
Assistance Publique - Hôpitaux de Paris1
Avidity Biosciences, Inc.1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Capricor Inc.1
Kyntra Bio1
Stealth BioTherapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Diseases15
Musculoskeletal Diseases8
Nervous System Diseases8
Neuromuscular Diseases8
Genetic Diseases, Inborn6
Muscular Disorders, Atrophic6
Muscular Dystrophies6
Muscular Dystrophy, Duchenne6
Genetic Diseases, X-Linked5
Muscular Atrophy4

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.